Numerous studies have been carried out on the redox activities of phenolic compounds from terrestrial plants, however, the redox pathway of phlorotannins, a type of marine algae-derived polyphenol, is far from clear. In the present study, the redox mechanisms of two phlorotannins, phloroglucinol (PL) and dieckol (DL), were comparatively scrutinized. Differential pulse voltammetry was conducted in the pH range 2.0–12.0 to determine the acid–base dissociation constant (pKa) and the number of electrons and protons involved in the redox reactions of two phlorotannins. Cyclic voltammetry was applied to obtain the heterogeneous electron transfer rate constant (k0). By means of computational calculation, UV-vis spectroscopy, and electrochemical analysis, it is proposed that PL oxidation in the whole pH range undergoes two steps which are dominated by proton-coupled electron transfer (PCET) (pH ≤ 9) and sequential proton-loss electron transfer (SPLET) mechanisms (pH > 9), respectively. In contrast, the multiple steps taking place in the DL oxidation process rely on PCET (pH ≤ 5), mixed SPLET/PCET (5 < pH ≤ 10), and electron transfer (pH > 10) mechanisms, respectively. Also, the lower proton affinity and ionization potential values of DL, which are attributed to its conjugated Cπ–O–Cπ moieties, lead to relatively higher redox activity as compared to PL in various chemical and cellular models. These findings may provide useful insights into the oxidative conversion of phlorotannins in their biological and chemical processes.
1 July 2019 in Asian Journal of Pharmaceutical Sciences
This study aimed to investigate the ability of the novel materials D-α-tocopheryl poly(2-ethyl-2-oxazoline) succinate (TPOS) to construct pH-sensitive liposomes. TPOS was initially synthesized and characterized by TLC, FTIR, and 1H-NMR. The buffering capacity of polyethylene glycol- distearoyl phosphatidylethanolamine (PEG-DSPE) and TPOS was determined by acid-base titration, and TPOS displayed a slower downtrend and gentler slope of titration curve than PEG-DSPE within pH 7.4-5.0. Studies on the in vitro drug release demonstrated that TPOS modified docetaxel (DOC) liposomes (TPOS-DOC-L) had a slower drug-release rate at pH 7.4 similar to PEGylated-DOC liposomes (PEG-DOC-L), whereas the release rate reached approximately 86.92% ± 1.69% at pH 6.4. In vitro cellular uptake assays by microplate reader, and flow cytometry revealed that TPOS modified coumarin 6 liposomes (TPOS-C6-L) had stronger cellular uptake at pH 6.4 than that at pH 7.4 (P < 0.01). Conversely, for PEGylated C6 liposomes (PEG-C6-L) and conventional C6 liposomes (C6-L), very similar cellular uptakes were exhibited at different pH values. Confocal laser scanning microscopy images showed that PEG-C6-L and C6-L were mainly located in lysosomes. By contrast, TPOS-C6-L showed broader cytoplasmic release and distribution at 4 h. MTT assay showed that the cytotoxicity of TPOS-DOC-L was similar to that of PEG-DOC-L and conventional DOC liposomes (DOC-L) at the same DOC concentration and at pH 7.4, but was much lower than those at pH 6.4 after 48 h of incubation. The apoptosis of PEG-DOC-L and DOC-L had no remarkable improvement with decreased pH from 7.4 to 6.4. Meanwhile, TPOS-DOC-L significantly induced the apoptosis of HeLa cells with decreased pH. Therefore, TPOS can be a biomaterial for the construction of a pH-sensitive drug delivery system.